Tempest Therapeutics TPST
NASDAQ TPST
$1.02 -0.05 (-4.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Gross Profit (2015 - 2018)

Tempest Therapeutics (TPST) posted Gross Profit of $11000.0 for Q3 2018, down 59.26% sequentially from $27000.0 in Q2 2018, and down 59.26% YoY from $27000.0 in Q3 2017.

Tempest Therapeutics (TPST) Gross Profit (2015 - 2018) Analysis & Trends

Tempest Therapeutics has reported Gross Profit for 4 years, with the latest figure at $11000.0 in Q3 2018.

  • Quarterly Gross Profit fell 59.26% year-over-year to $11000.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was -$134000.0 (up 92.03% YoY) and the FY2017 annual result came in at -$495000.0, up 89.57% from the prior year.
  • Gross Profit declined to $11000.0 in Q3 2018 per TPST's latest filing, from $27000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $27000.0 in Q3 2017 and troughed at -$1.4 million in Q3 2016.
  • A 4-year average of -$481533.3 and a median of -$190000.0 in 2017 frame the typical range for Gross Profit.
  • The sharpest annual moves came in 2016 and 2018: Gross Profit slumped 5050.0% in 2016, then jumped 114.21% in 2018.
  • Over 4 years, Gross Profit stood at -$1.0 million in 2015, then slumped by 31.07% to -$1.3 million in 2016, then jumped by 90.32% to -$127000.0 in 2017, then soared by 108.66% to $11000.0 in 2018.
  • According to Business Quant data, Gross Profit over the past three periods registered $11000.0, $27000.0, and -$45000.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Tempest Therapeutics 4.23 Mn 3.43 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2018 11,000.00
Sep 30, 2018 11,000.00
Jun 30, 2018 27,000.00
Jun 30, 2018 27,000.00
Mar 31, 2018 -45,000.00
Mar 31, 2018 -45,000.00
Dec 31, 2017 -127,000.00
Dec 31, 2017 -127,000.00
Sep 30, 2017 27,000.00
Sep 30, 2017 27,000.00
Jun 30, 2017 -190,000.00
Jun 30, 2017 -190,000.00
Mar 31, 2017 -206,000.00
Mar 31, 2017 -206,000.00
Dec 31, 2016 -1.31 Mn
Dec 31, 2016 -1.31 Mn
Sep 30, 2016 -1.36 Mn
Sep 30, 2016 -1.36 Mn
Jun 30, 2016 -1.04 Mn
Jun 30, 2016 -1.04 Mn